BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Genetown

  Insulet Announces Private Offering $300M of Convertible Senior Notes

  Insulet announced its intention to offer, subject to market and other conditions, $300 million principal amount of convertible senior notes due 2024 (the Notes) in a private placement.

  November 7, 2017

   · 

  3 min read
• Business

  Aurinia Pharmaceuticals to Release Third Quarter 2017 Financial Results on November 14, 2017

  At 4:30 p.m. Eastern Time Aurinia’s management will host a conference call to discuss the company’s financial results for the third quarter 2017 and provide a general business update.

  November 7, 2017

   · 

  1 min read
• Business

  Veracyte Announces Third Quarter 2017 Financial Results

  For the third quarter of 2017, revenue was $17.5 million, compared to $18.6 million for the third quarter of 2016.

  November 7, 2017

   · 

  12 min read
• Business

  IntriCon Reports 2017 Third-Quarter Results

  For the 2017 third quarter, the company reported net sales of $24.0 million, up 54.4 percent from $15.6 million in the prior-year period.

  November 7, 2017

   · 

  13 min read
• Business

  Myomo Reports Third Quarter 2017 Results

  Total revenue for the third quarter increased 165% year over year to $489,000, compared to $184,000 for the third quarter of 2016.

  November 7, 2017

   · 

  15 min read
• Business

  McKesson Strengthens Its Portfolio of Manufacturer Solutions With the Acquisition of RxCrossroads

  McKesson Corporation today announced that it has signed a definitive agreement to purchase RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health Corporation (NYSE:CVS).

  November 7, 2017

   · 

  6 min read
• Business

  ERYTECH Reports Third Quarter 2017 Financial Results and Provides Business Update

  Net loss for the nine-month period ended September 30, 2017 was €20.8 million, compared to €16.1 million for the same period in the prior year.

  November 7, 2017

   · 

  13 min read
• Pharm Country

  Merck Animal Health Introduces Care & Control of Pet Diabetes to Help Pet Owners Deal With the Disease

  Merck Animal Health has launched Care & Control of Pet Diabetes Featuring Sugar & Spike, a global educational program to provide pet owners with the tools they need to help manage their pets’ diabetes.

  November 7, 2017

   · 

  6 min read
• BioMidwest

  Symphony Clinical Research Earns WBENC Distinction for Fourth Consecutive Year

  Symphony Clinical Research received national re-certification as a Women’s Business Enterprise by the Women’s Business Development Center-Chicago, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC).

  November 7, 2017

   · 

  2 min read
• Drug Development

  Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of Dengue in Children and Adolescents; New 18-Month Interim Phase II Data Published in The Lancet Infectious Diseases

  The results of this interim analysis, a pre-planned evaluation of data from an ongoing trial, show that TAK-003 is associated with a reduction in the incidence of dengue in children and adolescents.

  November 7, 2017

   · 

  10 min read